Related Experiment Video
Updated: Jul 18, 2026

06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
Modeling Multi-View Dependence in Bayesian Networks for Alzheimer's Disease Detection
Parvathy Sudhir Pillai1, Tze-Yun Leong1,
1School of Computing, National University of Singapore, Singapore.
Studies in Health Technology and Informatics
|August 24, 2019
Summary
This study introduces a new framework for early Alzheimer's disease detection using diverse data. The interpretable models improve prediction accuracy for different disease stages.
Area of Science:
- Neuroscience
- Biomedical Informatics
- Machine Learning
Background:
- Early detection of Alzheimer's disease (AD) is crucial for timely interventions.
- Current diagnostic methods may not fully integrate diverse patient data.
- Identifying distinct disease stages aids in personalized treatment strategies.
Purpose of the Study:
- To develop a multi-view dependence modeling framework for early Alzheimer's disease detection.
- To integrate heterogeneous data types for improved disease staging.
- To create interpretable models for understanding disease progression.
Main Methods:
- Utilized a multi-view dependence modeling framework.
- Integrated neuro-images, biological markers, clinical data, and genotypical information.
- Employed Bayesian Networks for learning data dependence structures and ensuring interpretability.
Main Results:
- The framework successfully distinguished patients across different Alzheimer's disease stages.
- Interpretable models quantified probabilistic dependencies among variables.
- Hybrid dependence models demonstrated enhanced prediction performance.
Conclusions:
- The proposed framework offers a robust approach for early Alzheimer's detection and staging.
- Integrating diverse data sources with interpretable models improves diagnostic capabilities.
- This method holds potential for advancing Alzheimer's disease research and clinical practice.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Multi-input and Multi-variable systems
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
In the absence of...
Multicompartment Models: Overview
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

